Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
Public ClinicalTrials.gov record NCT03603288. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
Study identification
- NCT ID
- NCT03603288
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Santhera Pharmaceuticals
- Industry
- Enrollment
- 161 participants
Conditions and interventions
Conditions
Interventions
- idebenone 150 mg film-coated tablets Drug
Drug
Eligibility (public fields only)
- Age range
- 11 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 3, 2018
- Primary completion
- Nov 24, 2020
- Completion
- Nov 24, 2020
- Last update posted
- Dec 2, 2021
2018 – 2020
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama - Birmingham, Child Health Research | Birmingham | Alabama | 35233 | — |
| Banner University of Arizona Medical Center | Tucson | Arizona | 85724 | — |
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | — |
| UC Davis Department of Physical Medicine and Rehabilitation | Sacramento | California | 95817 | — |
| Center for Integrative Rare Disease Research, Rare Disease Research, LLC | Atlanta | Georgia | 30318 | — |
| University of Iowa, Department of Pediatrics | Iowa City | Iowa | 52242 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Children's Hospital Boston, Harvard Medical School, Department of Neurology | Boston | Massachusetts | 02115 | — |
| Gillette Children's Specialty Healthcare | Saint Paul | Minnesota | 55101 | — |
| Neurosciences Institute, Neurology - Charlotte Carolinas Healthcare System | Charlotte | North Carolina | 28207 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109-1988 | — |
| Children's Hospital of Philadelphia, Division of Pulmonology | Philadelphia | Pennsylvania | 19104-1771 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03603288, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03603288 live on ClinicalTrials.gov.